Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | +1.12% | -0.73% | +8.40% |
May. 02 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M | MT |
Sales 2024 * | 11.87M 8.66M | Sales 2025 * | 8.36M 6.1M | Capitalization | 697M 509M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 58.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 83.4 x |
P/E ratio 2024 * |
-6.73
x | P/E ratio 2025 * |
-6.62
x | Employees | 73 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.66% |
Latest transcript on Arbutus Biopharma Corporation
1 day | +1.12% | ||
1 week | -0.73% | ||
Current month | -0.73% | ||
1 month | -7.19% | ||
3 months | +13.87% | ||
6 months | +41.15% | ||
Current year | +8.40% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 14-06-30 | |
David Hastings
DFI | Director of Finance/CFO | 62 | 18-06-10 |
Karen Sims
CTO | Chief Tech/Sci/R&D Officer | 53 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 14-11-30 | |
James Meyers
BRD | Director/Board Member | 59 | 18-10-22 |
Daniel Burgess
BRD | Director/Board Member | 62 | 17-03-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 2.71 | +1.12% | 683,613 |
24-05-02 | 2.68 | -0.37% | 673,239 |
24-05-01 | 2.69 | -1.47% | 1,028,210 |
24-04-30 | 2.73 | -1.80% | 1,011,387 |
24-04-29 | 2.78 | +1.83% | 626,162 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.40% | 504M | |
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-15.94% | 31.09B | |
+52.66% | 24.74B | |
-14.50% | 15.91B | |
-9.12% | 11.96B | |
-14.38% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- ABUS Stock